Matching slides 41,369
Current window 28,891-28,920
Pages 1,379
Rows per page 30
Component: Calloutclear collectionreset all

Component

28,891-28,920 of 41,369

filter-aware
19
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
23
Includes a map-based visualization of regional product performance and a donut chart for revenue breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
27
Includes product imagery for Solta Medical brands (Thermage, Clear + Brilliant, Fraxel, Vaser).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
32
Includes disclaimer about non-retouched photos and medical source credits.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a flow diagram to show how business lines were reallocated between two reporting periods.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The slide highlights a 1% organic revenue decline for the segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
Includes segment-specific revenue and operating expense breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide includes a specific callout for the revenue decline of the WELLBUTRIN/APLENZIN product line.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
Includes non-GAAP metrics and segment-specific growth rates.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
52
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
53
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
54
The slide highlights a 7% decline in combined WELLBUTRIN/APLENZIN revenue.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
64
Includes footnotes regarding non-GAAP adjustments and corporate allocation exclusions.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
66
The slide contains two distinct tables: one for Revenue and one for EBITA (non-GAAP).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
07
The slide uses a hub-and-spoke style diagram to show how integrated capabilities feed into the pipeline.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
08
The slide uses a comparison structure to contrast two primary therapeutic areas.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
11
Slide 11 from a BioNTech presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
13
Includes immunobridging data and efficacy summary across age groups.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
20
Includes a process flow diagram illustrating the current standard of care and patient outcomes.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
21
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
27
The slide highlights immune activation markers and clinical disease control correlations, setting the stage for a Phase 2 trial.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
08
The slide uses a chronological progression (Prior State, Current State, Planned Future State) to demonstrate growth in product variety.Blue Apron | Investor Presentation Deck | 10 slides · Blue Apron
Pitch deck Investor relations Beat · RoadmapLoop · Why Now1 hit
25
The slide uses a 'Current vs Future' state comparison to illustrate scalability.Boxed | SPAC Presentation Deck | 53 slides · Boxed
Pitch deck Investment bank 1 hit
38
The slide uses a horizontal line to visually anchor the company's valuation against the peer group.Boxed | SPAC Presentation Deck | 53 slides · Boxed
Pitch deck Investment bank 1 hit
39
The slide uses bar charts to compare Boxed against industry peers in three segments.Boxed | SPAC Presentation Deck | 53 slides · Boxed
Pitch deck Investment bank 1 hit
12
The chart uses a waterfall bridge to show the transition from $650M to $751M, with a sub-calculation for organic growth.Broadridge Financial Solutions | Results Presentation Deck | 27 slides · Broadridge
Conference presentation Investor relations Beat · Growth PotentialLoop · Cost Of Inaction1 hit
07
The slide uses a donut chart to illustrate market segmentation of Medicare Advantage enrollees.Cano Health | Investor Presentation Deck | 22 slides · Cano Health
Pitch deck Investor relations Beat · Solution1 hit
12
The slide uses a comparative bar chart structure to highlight performance improvements.Cano Health | Investor Presentation Deck | 22 slides · Cano Health
Pitch deck Investor relations Beat · Traction1 hit